A single-center study found anti-COVID-19 protection lowest in patients with MM at 2 weeks after their second BNT162b2 mRNA shot than did patients with myeloproliferative malignancies, and was highest in older patients without cancer.
During a residential rehabilitation program, researchers interviewed participants to determine their supportive care and rehabilitation needs.
Researchers compared outcomes in patients with PCNSL who did not meet clinical trial criteria with those of patients from a major multicenter clinical trial of PCNSL.
Researchers sought to determine if knowing treatment assignment would lead to patient bias among participants in multiple myeloma clinical trials.
A data analysis identified risk factors and support sources that may influence a patient’s decision regarding chemotherapy to treat their colorectal cancer.
Researchers sought to determine the effect this regimen on outcomes for patients with early-stage non-small cell lung cancer.
Researchers sought to determine whether patient reports have potential as prognostic markers in patients with advanced breast cancer treated with a CDK4/6 inhibitor.
A meta-analysis of phase 3 randomized control trials sought to identify the TRAEs associated with 7 therapeutic regimens for the treatment of mRCC.
Researchers sought to determine the effects of fasting on drug absorption and efficacy in patients receiving TKIs for chronic myeloid leukemia.
Results of a retrospective cohort study shows the impact of COVID-19 pandemic on screening rates for breast, prostate, and colorectal cancer.
